Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 4, 2012
On July 26th 2012, the governing board of California's Stem Cell Agency approved an $18 million Disease Team research grant that aims to bring a stem cell-based ALS treatment to clinical trials. The project team is led by Clive Svendsen, PhD, director of the Cedars-Sinai Regenerative Medicine Institute and chair of the California ALS Research Network. For more info about CIRM-funded ALS research, see our fact sheet: http://www.cirm.ca.gov/ALS_facts